vaccineimpact
The UK Government’s reporting system for COVID vaccine adverse reactions from the Medicines and Healthcare products Regulatory Agency released their latest report today, March 18, 2021.
The report covers data collected from December 9, 2020, through March 7, 2021, for the two experimental COVID vaccines currently in use in the U.K. from Pfizer and AstraZeneca.
They report a total of 534 deaths and 330,063 injuries.
For the COVID-19 mRNA Pfizer- BioNTech vaccine analysis they report:
- 2500 Blood disorders including 1 death
- 1226 Cardiac disorders including 27 deaths
- 5 Congenital disorder
- 893 Ear disorders
- 14 Endocrine disorders
- 1489 Eye disorders
- 11,193 Gastrointestinal disorders including 13 deaths
- 30,533 General disorders including 114 deaths
- 21 Hepatic disorders
- 560 Immune system disorders
- 2210 Infections including 38 deaths
- 500 Injuries including 1 death
- 1142 Investigations
- 629 Metabolic disorders including 1 death
- 13,624 Muscle & tissue disorders including 1 death
- 27 Neoplasms
- 19,142 Nervous system disorders including 17 deaths
- 39 Pregnancy conditions including 1 death
- 1499 Psychiatric disorders
- 227 Renal & urinary disorders
- 442 Reproductive & breast disorders
- 3276 Respiratory disorders including 15 deaths
- 7308 Skin disorders including 1 death
- 24 Social circumstances
- 67 Surgical & medical procedures
- 1205 Vascular disorders including 1 death
Total reactions for the COVID-19 mRNA Pfizer- BioNTech vaccine: 237 deaths and 100,809 injuries
For the COVID-19 vaccine Oxford University/AstraZeneca analysis they report:
- 1287 Blood disorders including 1 death
- 2200 Cardiac disorders including 38 deaths
- 19 Congenital disorders
- 1424 Ear disorders
- 42 Endocrine disorders
- 2499 Eye disorders
- 25,613 Gastrointestinal disorders including 5 deaths
- 80,954 General disorders including 163 deaths
- 41 Hepatic disorders
- 633 Immune system disorders
- 4382 Infections including 40 deaths
- 1086 Injuries including 1 death
- 2767 Investigations
- 2952 Metabolic disorders including 2 deaths
- 27,948 Muscle & tissue disorders
- 21 Neoplasms including 1 death
- 49,655 Nervous system disorders including 20 deaths
- 25 Pregnancy conditions
- 4046 Psychiatric disorders
- 641 Renal & urinary disorders including 1 death
- 354 Reproductive & breast disorders
- 6040 Respiratory disorders including 12 deaths
- 12,803 Skin disorders
- 52 Social circumstances
- 170 Surgical & medical procedures including 1 death
- 1843 Vascular disorders including 3 deaths
Total reactions for the COVID-19 vaccine Oxford University/AstraZenec vaccine: 289 deaths and 228,337 injuries
For the COVID-19 vaccine brand unspecified analysis they report:
- 3 Blood disorders
- 4 Cardiac disorder including 1 death
- 9 Ear disorders
- 13 Eye disorders
- 89 Gastrointestinal disorders
- 324 General disorders including 4 deaths
- 1 Hepatic disorders
- 2 Immune system disorders
- 13 Infections including 1 death
- 7 Injuries
- 12 Investigations
- 30 Metabolic disorders
- 87 Muscle & tissue disorders
- 199 Nervous system disorders
- 24 Psychiatric disorders
- 8 Renal & urinary
- 1 Reproductive & breast disorders
- 26 Respiratory disorders including 2 deaths
- 57 Skin disorders
- 1 Social circumstances
- 7 Vascular disorders
Total reactions for the COVID-19 vaccine brand unspecified vaccines: 8 deaths and 917 injuries.
The UK Medicines and Healthcare products Regulatory Agency concludes:
The overall safety experience with both vaccines is so far as expected from the clinical trials.
Based on current experience, the expected benefits of both COVID-19 vaccines in preventing COVID-19 and its serious complications far outweigh any known side effects.
In spite of the fact that over 20 countries have now suspended vaccination programs with the AstraZeneca experimental vaccine due to reports of fatal blood clots, the European Medicines Agency (EMA) concluded that there was no link between the AstraZeneca experimental COVID vaccines and the fatal blood clots, and urged countries to resume vaccinations because “the benefits outweigh the risks.” See:
